EGA
ENZ

Eagle Global Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Eagle Global Advisors’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-73,200
Closed -$808K – 374
2017
Q2 		$808K Sell
73,200
-39,000
-35% -$363K 0.02% 163
2017
Q1 		$939K Hold
112,200
– – 0.03% 153
2016
Q4 		$779K Buy
112,200
+13,400
+14% +$85.5K 0.02% 162
2016
Q3 		$503K Buy
98,800
+36,590
+59% +$219K 0.01% 210
2016
Q2 		$371K Buy
62,210
+40,930
+192% +$227K 0.01% 235
2016
Q1 		$97K Buy
+21,280
New +$94.7K ﹤0.01% 353

Other funds holding ENZ

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EGA
Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eagle Global Advisors's ENZ Position: Q3 2017 in Review

Eagle Global Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q3 2017, closing a stake of 73,200 shares — an estimated $808K sold.

Eagle Global Advisors first reported a position in ENZ in Q1 2016 and held it in 6 quarters. The position peaked at $939K in Q1 2017. 116 funds tracked by Wall St. Rank hold ENZ as of Q3 2017.

  • Eagle Global Advisors reported no remaining Enzo Biochem, Inc. position as of Q3 2017 after selling out during the quarter.
  • Eagle Global Advisors sold 73,200 Enzo Biochem, Inc. shares in Q3 2017, an estimated $808K.
  • Eagle Global Advisors first reported a position in Enzo Biochem, Inc. in Q1 2016 and held it in 6 quarters.
  • Eagle Global Advisors's Enzo Biochem, Inc. position peaked at $939K in Q1 2017.
  • 116 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2017.

Based on Eagle Global Advisors's 13F filing for Q3 2017, filed 13 Nov 2017.